Unlike vials, flexible films could preserve medicines for long periods, with no refrigeration needed
Some experts caution we should temper our expectations about the much-touted approach
Biotechs and pharma want to protect patients without triggering immune system havoc
Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news
Mosquitoes that like to bite at night are being thwarted by bed nets, leading to the rise of populations that prefer to bite when the nets are not up yet.
Scientists urge caution over hints of success emerging from small human and animal studies
Some individuals choosing physician-assisted death donate their tissue to science.
Different species are helping answer different questions about COVID-19 in humans in order to develop vaccines and treatments
Blood tests that find malignancies before they spread could transform our approach to treatment...
The pandemic is no excuse to abandon chronic disease management and prevention
Despite conflicting data, the highly anticipated results will make the treatment a standard of care in the United States
Amyloid, the leading target for dementia therapy, faces skepticism after drug failures
With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies
Compassionate use of experimental medicine needs to coexist with scientific rigor to help patients, researchers write in the journal Science
Support grows for a controversial ‘human challenge’ vaccine study—but no trial is yet planned
Research into the brain’s protein-disposal systems, electrical activity and three other areas looks promising
Many hospitalized victims are developing potentially lethal secondary coinfections such as bacterial pneumonia and sepsis
Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials
In mice, a test for lung cancer involves nanoprobes that recognize tumors and send reporter molecules into the urine for simple analysis.
A new era for Alzheimer’s and journalism in the time of coronavirus